Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study

Stegmayr, Bernd ; Almroth, Gabriel ; Berlin, Gösta ; Fehrman, Ingela ; Kurkus, Jan LU ; Norda, Rut ; Olander, R ; Sterner, Gunnar LU ; Thysell, Hans LU and Wickström, Björn , et al. (1999) In International Journal of Artificial Organs 22(2). p.81-87
Abstract
A therapeutic removal of antibodies may be achieved by immunoadsorption (IA) or by plasma exchange (PE). The aim of this prospective randomised study was to compare the efficacy of these different techniques with regard to treatment of patients with rapidly progressive glomerulonephritis (RPG) having at least 50% crescents. Forty-four patients with a RPG were included for treatment either by IA or PE (with albumin as substitution for removed plasma). All patients were additionally treated with immunosuppression. A median of 6 sessions of PEs were performed in 23 patients compared with 6 IAs in 21 patients. Goodpasture's syndrome (GP) was present in 6 patients (PE 3, IA 3). All of them started and ended in dialysis, two died. Among the... (More)
A therapeutic removal of antibodies may be achieved by immunoadsorption (IA) or by plasma exchange (PE). The aim of this prospective randomised study was to compare the efficacy of these different techniques with regard to treatment of patients with rapidly progressive glomerulonephritis (RPG) having at least 50% crescents. Forty-four patients with a RPG were included for treatment either by IA or PE (with albumin as substitution for removed plasma). All patients were additionally treated with immunosuppression. A median of 6 sessions of PEs were performed in 23 patients compared with 6 IAs in 21 patients. Goodpasture's syndrome (GP) was present in 6 patients (PE 3, IA 3). All of them started and ended in dialysis, two died. Among the remaining 38 patients (26 men, 12 women) 87% had antibodies to ANCA. Creatinine clearance for PE versus IA were at a median at start 17.1 and 19.8 ml/min, and at 6 months 49 and 49 ml/min, respectively. At 6 months 7 of 10 patients did not need dialysis (remaining: IA 0/5 and PE 2/5, n.s.). The extent of improvement did not differ between the groups. Three patients died during the observation period of 6 months (IA 2; PE 1, on HD). Although no difference was found between the IA or the PE group this study shows that the protocol used was associated with an improved renal function in most patients (except for Goodpasture's syndrome) whereas 70% of them could leave the dialysis program. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
subject
in
International Journal of Artificial Organs
volume
22
issue
2
pages
81 - 87
publisher
Wichtig Editore - Milano (Italy)
external identifiers
  • scopus:0032902702
ISSN
1724-6040
DOI
10.1177/039139889902200205
language
English
LU publication?
no
id
983285ec-1b29-4f1b-a21c-0187d934be7d
date added to LUP
2019-10-27 15:23:19
date last changed
2022-02-16 00:46:31
@article{983285ec-1b29-4f1b-a21c-0187d934be7d,
  abstract     = {{A therapeutic removal of antibodies may be achieved by immunoadsorption (IA) or by plasma exchange (PE). The aim of this prospective randomised study was to compare the efficacy of these different techniques with regard to treatment of patients with rapidly progressive glomerulonephritis (RPG) having at least 50% crescents. Forty-four patients with a RPG were included for treatment either by IA or PE (with albumin as substitution for removed plasma). All patients were additionally treated with immunosuppression. A median of 6 sessions of PEs were performed in 23 patients compared with 6 IAs in 21 patients. Goodpasture's syndrome (GP) was present in 6 patients (PE 3, IA 3). All of them started and ended in dialysis, two died. Among the remaining 38 patients (26 men, 12 women) 87% had antibodies to ANCA. Creatinine clearance for PE versus IA were at a median at start 17.1 and 19.8 ml/min, and at 6 months 49 and 49 ml/min, respectively. At 6 months 7 of 10 patients did not need dialysis (remaining: IA 0/5 and PE 2/5, n.s.). The extent of improvement did not differ between the groups. Three patients died during the observation period of 6 months (IA 2; PE 1, on HD). Although no difference was found between the IA or the PE group this study shows that the protocol used was associated with an improved renal function in most patients (except for Goodpasture's syndrome) whereas 70% of them could leave the dialysis program.}},
  author       = {{Stegmayr, Bernd and Almroth, Gabriel and Berlin, Gösta and Fehrman, Ingela and Kurkus, Jan and Norda, Rut and Olander, R and Sterner, Gunnar and Thysell, Hans and Wickström, Björn and Wirén, JE}},
  issn         = {{1724-6040}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{81--87}},
  publisher    = {{Wichtig Editore - Milano (Italy)}},
  series       = {{International Journal of Artificial Organs}},
  title        = {{Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study}},
  url          = {{http://dx.doi.org/10.1177/039139889902200205}},
  doi          = {{10.1177/039139889902200205}},
  volume       = {{22}},
  year         = {{1999}},
}